Evogene Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Evogene Limited with three other
miscellaneous service companies in Middle East:
Kitov Pharma Ltd
sales of 3.60 million Israel Shekels [US$1.04 million]
of which 100%
was Pain and Hypertension),
Collplant Holdings Ltd
(18.03 million Israel Shekels [US$5.19 million]
Hadasit Bio Holding Ltd.
(250,000.00 Israel Shekels [US$71,942.50 ]
Evogene Limited reported sales of 6.30 million Israel Shekels (US$1.81 million)
December of 2018.
decrease of 47.8%
versus 2017, when the company's sales were 12.07 million Israel Shekels.
Contributing to the drop in overall sales was the 49.0% decline
in Agricultural Crops, from 11.60 million Israel Shekels to 5.92 million Israel Shekels.
There were also decreases in sales in
Alternative Fuels (down 20.1% to 382,119.40 Israel Shekels)